Activation of the p75 Neurotrophin Receptor through Conformational Rearrangement of Disulphide-Linked Receptor Dimers-Reference-Cited by-同舟云学术

Activation of the p75 Neurotrophin Receptor through Conformational Rearrangement of Disulphide-Linked Receptor Dimers

Published:2009-04 Issue:1 Volume:62 Page:72-83
ISSN:0896-6273
Container-title:Neuron
language:en
Short-container-title:Neuron

Author:

Vilar Marçal,Charalampopoulos Ioannis,Kenchappa Rajappa S.,Simi Anastasia,Karaca Esra,Reversi Alessandra,Choi Soyoung,Bothwell Mark,Mingarro Ismael,Friedman Wilma J.,Schiavo Giampietro,Bastiaens Philippe I.H.,Verveer Peter J.,Carter Bruce D.,Ibáñez Carlos F.

Publisher

Elsevier BV

Subject

General Neuroscience

Reference52 articles.

1. Apoptosis control by death and decoy receptors;Ashkenazi;Curr. Opin. Cell Biol.,1999

2. p75NTR is positively promiscuous: novel partners and new insights;Barker;Neuron,2004

3. Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system;Bibel;Genes Dev.,2000

4. Evolution of the neurotrophin signaling system in invertebrates;Bothwell;Brain Behav. Evol.,2006

5. Multi-tasking by the p75 neurotrophin receptor: sortilin things out?;Bronfman;EMBO Rep.,2004

Cited by 132 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor necrosis factor α receptor 1A transduces the inhibitory effect on axon regeneration triggered by IgG anti-ganglioside GD1a antibodies;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-10

2. Fluoxetine and Ketamine Enhance Extinction Memory and Brain Plasticity by Triggering the p75 Neurotrophin Receptor Proteolytic Pathway;Biological Psychiatry;2024-06

3. Multimodal beneficial effects of BNN27, a Nerve Growth Factor synthetic mimetic, in the 5xFAD mouse model of Alzheimer’s Disease;2024-02-28

4. RhoGDI phosphorylation by PKC promotes its interaction with death receptor p75NTR to gate axon growth and neuron survival;EMBO Reports;2024-01-22

5. The p75 neurotrophin receptor;HIV-Associated Neurocognitive Disorders;2024